Stratos Wealth Advisors, LLC Applied Therapeutics Inc. Transaction History
Stratos Wealth Advisors, LLC
- $1.82 Billion
- Q2 2025
A detailed history of Stratos Wealth Advisors, LLC transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Stratos Wealth Advisors, LLC holds 12,105 shares of APLT stock, worth $5,326. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,105Holding current value
$5,326% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding APLT
# of Institutions
92Shares Held
102MCall Options Held
176KPut Options Held
165K-
Vestal Point Capital, LP New York, NY11.5MShares$5.06 Million0.4% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA11.3MShares$4.97 Million6.41% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.4MShares$4.57 Million0.0% of portfolio
-
Knoll Capital Management, LLC Miami, FL7.8MShares$3.43 Million2.55% of portfolio
-
Black Rock Inc. New York, NY6.57MShares$2.89 Million0.0% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $21.1M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...